Regulus Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $302 |
Gross Profit | -89 | -81 | 226 | |
EBITDA | -13,967 | -10,888 | -8,307 | -7,871 |
EBIT | -14,057 | -10,977 | -8,388 | -7,947 |
Net Income | -14,062 | -11,036 | -8,469 | -8,061 |
Net Change In Cash | 0 | 0 | 0 | 302 |
Free Cash Flow | -9,477 | -11,720 | -8,971 | -6,196 |
Cash | 26,373 | 17,184 | 29,648 | 23,829 |
Basic Shares | 65,471 | 64,465 | 28,746 | 20,222 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $10 | $10,006 |
Gross Profit | -21,152 | -122 | -459 | 10,006 |
EBITDA | -30,882 | -28,117 | -27,357 | -13,688 |
EBIT | -31,109 | -28,239 | -27,816 | -14,155 |
Net Income | -30,037 | -28,323 | -27,808 | -15,263 |
Net Change In Cash | 0 | 0 | 10 | 10,006 |
Cost of Revenue | -3,034 | |||
Free Cash Flow | -27,381 | -25,887 | -24,379 | -12,547 |
Cash | 23,767 | 24,228 | 60,383 | 31,087 |
Basic Shares | 18,960 | 15,259 | 8,570 | 3,497 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.21 |
2024-06-30 | -$0.17 |
2024-03-31 | -$0.29 |
2023-12-31 | -$0.40 |
